Board

Dr Brad Walsh

Dr Brad Walsh

Executive Director and CEO

Brad brings over 30 years of experience in biotechnology business and has enjoyed a successful career commercialising immunoassay kits, proteomics technologies and consumables, and bioinformatics software. His products are being sold and supplied by major US corporations, such as Bio-Rad Laboratories.

He is the founder of Minomic and in the early 2000’s started the predecessor of Minomic International Ltd as a private company, raising over $5M in equity investment and non-dilutive funding. In the mid-90’s he was the inaugural General Manager of an Australian National Research Facility, which was the world leader in the groundbreaking new field of proteomics.

Prior to this, he led research groups in public institutions such as CSIRO, universities, and hospitals. His expertise and opinion as a thought leader and technologist has been eagerly sought by industry and government. He currently holds the position of Adjunct Professor at Macquarie University.

Dr Stewart Washer

Dr Stewart Washer

Non-executive Chairman

Stewart has 25 years of CEO and Board experience in medical and agrifood biotech companies. He is currently the Executive Director of Zelda Therapeutics Ltd (ASX:ZLD) in the medicinal cannabis space, Chairman of Orthocell Ltd (ASX:OCC), a regenerative medicine company, Founding Chairman and current Director of Cynata Therapeutics Ltd (ASX:CYP) who are developing global stem cell therapies and Chairman of Minomic International Ltd with a novel approach to cancer diagnosis and treatment.  He is also a founder and consultant to AusCann Ltd (ASX:AC8), the largest medicinal cannabis company in Australia.

Stewart has previously worked in life science Fund Management with BioScience Managers in Australia and the Nestlé Fund Inventages.

Stewart has held a number of Board positions in the past, including Chairman of Hatchtech Pty Ltd that was sold in 2015 for A$279m and was a Director of iCeutica that was sold to a US Pharma. He was also a Senator with Murdoch University and was a Director of AusBiotech Ltd.

Mr Raymore Millard

Mr Raymore Millard

Non-executive Director

Mr. Raymore Millard holds extensive experience in providing strategic advice to both listed and unlisted companies in Australia and overseas. He has assisted various companies from raising seed capital, through to their ultimate listing. He is similarly assisting Minomic.
Mr Xueliang Huang

Mr Xueliang Huang

Non-executive Director

Mr. Huang is a major shareholder in Minomic.  He has investment experience in both Australia and China. He is also a director of Super New Generation Pty Limited.
Privacy Policy